AXA SA (CS.PA)
FR0000120628 - Common Stock
We assign a fundamental rating of 6 out of 10 to CS. CS was compared to 32 industry peers in the Insurance industry. CS has an average financial health and profitability rating. CS has a correct valuation and a medium growth rate. Finally CS also has an excellent dividend rating. This makes CS very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
In the past year CS was profitable.
In the past year CS had a positive cash flow from operations.
In the past 5 years CS has always been profitable.
CS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 1.12%, CS is doing good in the industry, outperforming 61.29% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.16%, CS is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
CS has a better Return On Invested Capital (1.32%) than 61.29% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CS is in line with the industry average of 2.06%.
The last Return On Invested Capital (1.32%) for CS is above the 3 year average (1.23%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROIC | 1.32% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
1.3 Margins
With a Profit Margin value of 8.20%, CS perfoms like the industry average, outperforming 48.39% of the companies in the same industry.
CS's Profit Margin has improved in the last couple of years.
CS has a Operating Margin of 11.69%. This is in the better half of the industry: CS outperforms 64.52% of its industry peers.
CS's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A |
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
Compared to 1 year ago, CS has less shares outstanding
The number of shares outstanding for CS has been reduced compared to 5 years ago.
CS has about the same debt/assets ratio as last year.
2.2 Solvency
Based on the Altman-Z score of 0.34, we must say that CS is in the distress zone and has some risk of bankruptcy.
CS has a Altman-Z score of 0.34. This is amongst the best in the industry. CS outperforms 87.10% of its industry peers.
The Debt to FCF ratio of CS is 3.32, which is a good value as it means it would take CS, 3.32 years of fcf income to pay off all of its debts.
CS's Debt to FCF ratio of 3.32 is fine compared to the rest of the industry. CS outperforms 64.52% of its industry peers.
CS has a Debt/Equity ratio of 0.57. This is a neutral value indicating CS is somewhat dependend on debt financing.
CS has a Debt to Equity ratio of 0.57. This is comparable to the rest of the industry: CS outperforms 58.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 0.34 |
ROIC/WACC0.13
WACC10.42%
2.3 Liquidity
CS has a Current Ratio of 1.00. This is a normal value and indicates that CS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CS (1.00) is better than 87.10% of its industry peers.
CS has a Quick Ratio of 1.00. This is a normal value and indicates that CS is financially healthy and should not expect problems in meeting its short term obligations.
CS has a better Quick ratio (1.00) than 87.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.49% over the past year.
The Earnings Per Share has been growing by 32.03% on average over the past years. This is a very strong growth
CS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.35%.
The Revenue has been decreasing by -4.60% on average over the past years.
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
3.2 Future
CS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.54% yearly.
CS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.50% yearly.
EPS Next Y8.13%
EPS Next 2Y9.64%
EPS Next 3Y7.88%
EPS Next 5Y5.54%
Revenue Next Year-9.58%
Revenue Next 2Y-2.55%
Revenue Next 3Y-1.67%
Revenue Next 5Y5.5%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.39, the valuation of CS can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 67.74% of the companies listed in the same industry.
CS is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
CS is valuated reasonably with a Price/Forward Earnings ratio of 8.22.
CS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CS is cheaper than 74.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CS to the average of the S&P500 Index (23.99), we can say CS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.39 | ||
| Fwd PE | 8.22 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CS is valued a bit cheaper than 61.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.2 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.28
PEG (5Y)0.32
EPS Next 2Y9.64%
EPS Next 3Y7.88%
5. Dividend
5.1 Amount
CS has a Yearly Dividend Yield of 5.86%, which is a nice return.
Compared to an average industry Dividend Yield of 5.17, CS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, CS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.86% |
5.2 History
The dividend of CS has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
62.10% of the earnings are spent on dividend by CS. This is not a sustainable payout ratio.
CS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.1%
EPS Next 2Y9.64%
EPS Next 3Y7.88%
AXA SA
EPA:CS (12/24/2024, 7:00:00 PM)
33.57
-0.07 (-0.21%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners41.04%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap74.33B
Analysts80.71
Price Target40.39 (20.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.86% |
Dividend Growth(5Y)4.19%
DP62.1%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.98%
PT rev (3m)4.45%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.39 | ||
| Fwd PE | 8.22 | ||
| P/S | 0.85 | ||
| P/FCF | 9.2 | ||
| P/OCF | 8.68 | ||
| P/B | 1.57 | ||
| P/tB | 3.03 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.23
EY9.62%
EPS(NY)4.08
Fwd EY12.17%
FCF(TTM)3.65
FCFY10.87%
OCF(TTM)3.87
OCFY11.52%
SpS39.51
BVpS21.38
TBVpS11.07
PEG (NY)1.28
PEG (5Y)0.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROCE | 1.63% | ||
| ROIC | 1.32% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.79% | ||
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A | ||
| FCFM | 9.24% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
ROICexc(3y)1.28%
ROICexc(5y)1.05%
ROICexgc(3y)1.64%
ROICexgc(5y)1.33%
ROCE(3y)1.52%
ROCE(5y)1.25%
ROICexcg growth 3Y24.63%
ROICexcg growth 5Y6.98%
ROICexc growth 3Y21.16%
ROICexc growth 5Y7.2%
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.55% | ||
| Interest Coverage | 1.51 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 112.61% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 0.34 |
F-Score7
WACC10.42%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.36%
Profit Quality(3y)112.32%
Profit Quality(5y)257.76%
High Growth Momentum
Growth
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
EPS Next Y8.13%
EPS Next 2Y9.64%
EPS Next 3Y7.88%
EPS Next 5Y5.54%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
Revenue Next Year-9.58%
Revenue Next 2Y-2.55%
Revenue Next 3Y-1.67%
Revenue Next 5Y5.5%
EBIT growth 1Y4.29%
EBIT growth 3Y12.44%
EBIT growth 5Y-0.05%
EBIT Next Year26.06%
EBIT Next 3Y9.55%
EBIT Next 5YN/A
FCF growth 1Y9.42%
FCF growth 3Y-33.47%
FCF growth 5Y-1.8%
OCF growth 1Y11.23%
OCF growth 3Y-32.45%
OCF growth 5Y-1.79%